Association between a promoter polymorphism of the paraoxonase PON1 gene and pathologically verified idiopathic Parkinson’s disease

Background:  Exposure to pesticide is associated with an elevated risk of Parkinson’s disease (PD). Oxidative stress is also implicated in the etiology of PD. Paraoxonase (PON1) detoxifies organophosphates and exhibits antioxidant properties. It was postulated that polymorphisms of the PON1 gene lead to increased risk of PD.

[1]  E. Schwartz,et al.  Paraoxonase 1 Met–Leu 54 polymorphism is associated with Parkinson’s disease , 2001, Journal of the Neurological Sciences.

[2]  R. Roth,et al.  Estrogen Is Essential for Maintaining Nigrostriatal Dopamine Neurons in Primates: Implications for Parkinson's Disease and Memory , 2000, The Journal of Neuroscience.

[3]  Z. Liu,et al.  No association between paraoxonase 1 (PON1) gene polymorphisms and susceptibility to Parkinson's disease in a Chinese population , 2000, Movement disorders : official journal of the Movement Disorder Society.

[4]  K. Lapane,et al.  Estrogen use among nursing home residents with a diagnosis of Parkinson's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.

[5]  D. L. Le Couteur,et al.  Paraoxonase polymorphisms, pesticide exposure and Parkinson's disease in a Caucasian population , 2000, Journal of Neural Transmission.

[6]  Y Ben-Shlomo,et al.  Cross sectional prevalence survey of idiopathic Parkinson's disease and parkinsonism in London , 2000, BMJ : British Medical Journal.

[7]  Y. Ikeda,et al.  A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression. , 2000, Atherosclerosis.

[8]  I. Leviev,et al.  Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[9]  H. Cohen,et al.  The anxiolytic effect of chronic inositol depends on the baseline level of anxiety , 2000, Journal of Neural Transmission.

[10]  P. Blanchet,et al.  Short-term effects of high-dose 17β-estradiol in postmenopausal PD patients , 1999, Neurology.

[11]  E. Schwartz,et al.  Gln → Arg 191 Polymorphism of Paraoxonase and Parkinson’s Disease , 1999, Human Heredity.

[12]  I. Kondo,et al.  Genetic polymorphism of paraoxonase 1 (PON1) and susceptibility to Parkinson's disease , 1998, Brain Research.

[13]  C. Shaw,et al.  The genetics of Parkinson’s disease and parkinsonian syndromes , 1998, Journal of Neurology.

[14]  J Q Trojanowski,et al.  Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. , 1998, The American journal of pathology.

[15]  T. Zama,et al.  A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[16]  J. Dartigues,et al.  Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[17]  D. Gjerde,et al.  Detection of single-nucleotide polymorphisms with the WAVE DNA fragment analysis system. , 1997, Genetic testing.

[18]  P. Froguel,et al.  Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. , 1997, The Journal of clinical investigation.

[19]  M. Keifer,et al.  The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin , 1996, Nature Genetics.

[20]  R. Hegele,et al.  Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins , 1996, Current opinion in lipidology.

[21]  P. Jenner.  Oxidative damage in neurodegenerative disease , 1994, The Lancet.

[22]  A. Rajput,et al.  Prevalence of movement disorders in elderly community residents. , 1994, Neuroepidemiology.

[23]  D. Adler,et al.  The molecular basis of the human serum paraoxonase activity polymorphism , 1993, Nature Genetics.

[24]  E. Love,et al.  Parkinson's disease and exposure to agricultural work and pesticide chemicals , 1992, Neurology.

[25]  A. Rajput,et al.  Accuracy of Clinical Diagnosis in Parkinsonism — A Prospective Study , 1991, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[26]  J. Langston,et al.  Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.

[27]  N. Blin,et al.  A general method for isolation of high molecular weight DNA from eukaryotes. , 1976, Nucleic acids research.

[28]  F. Mahoney,et al.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 2018, Maryland state medical journal.